IRIS Trademark

Trademark Overview


On Friday, March 24, 2023, a trademark application was filed for IRIS with the United States Patent and Trademark Office. The USPTO has given the IRIS trademark a serial number of 97855498. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, October 31, 2024. This trademark is owned by Iris Medicine, Inc.. The IRIS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of genetic diseases, namely, neurological diseases; pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of genetic diseases, namely, neurological diseases

Clinical preparations in the nature of RNA and genetic material, namely, plasmids, DNA, and chemically-modified RNA encoding RNA for use in the manufacture of medical preparations for treatment of genetic diseases

Development of pharmaceutical preparations and medicines for genetic diseases, namely, neurological diseases; testing, inspection, research, and development of pharmaceutical preparations for genetic diseases, namely, neurological diseases; none of the foregoing research services directed to providing a database comprising patient records to others in the fields of eyecare or ophthalmology
iris

General Information


Serial Number97855498
Word MarkIRIS
Filing DateFriday, March 24, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, October 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized letters "IRIS" with a dashed arc shape appearing above the mark, connecting the two letter "I".
Goods and ServicesPharmaceutical preparations for the treatment of genetic diseases, namely, neurological diseases; pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of genetic diseases, namely, neurological diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesClinical preparations in the nature of RNA and genetic material, namely, plasmids, DNA, and chemically-modified RNA encoding RNA for use in the manufacture of medical preparations for treatment of genetic diseases
Goods and ServicesDevelopment of pharmaceutical preparations and medicines for genetic diseases, namely, neurological diseases; testing, inspection, research, and development of pharmaceutical preparations for genetic diseases, namely, neurological diseases; none of the foregoing research services directed to providing a database comprising patient records to others in the fields of eyecare or ophthalmology

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSunday, April 16, 2023
Primary Code001
First Use Anywhere DateWednesday, August 9, 2023
First Use In Commerce DateWednesday, August 9, 2023

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, April 16, 2023
Primary Code005
First Use Anywhere DateWednesday, August 9, 2023
First Use In Commerce DateWednesday, August 9, 2023

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, April 16, 2023
Primary Code042
First Use Anywhere DateTuesday, June 13, 2023
First Use In Commerce DateTuesday, June 13, 2023

Trademark Owner History


Party NameIris Medicine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerkeley, CA 94704

Trademark Events


Event DateEvent Description
Tuesday, March 28, 2023NEW APPLICATION ENTERED
Sunday, April 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 18, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, September 14, 2023ASSIGNED TO EXAMINER
Friday, September 22, 2023TEAS AMENDMENT OF USE RECEIVED
Saturday, September 23, 2023USE AMENDMENT FILED
Saturday, September 23, 2023AMENDMENT TO USE PROCESSING COMPLETE
Thursday, September 28, 2023USE AMENDMENT ACCEPTED
Friday, September 29, 2023NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, October 3, 2023NON-FINAL ACTION WRITTEN
Tuesday, October 3, 2023NON-FINAL ACTION E-MAILED
Tuesday, October 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 22, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 22, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 23, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 29, 2024FINAL REFUSAL WRITTEN
Monday, January 29, 2024FINAL REFUSAL E-MAILED
Monday, January 29, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, April 23, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, April 23, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, July 12, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, July 12, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, July 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 29, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, July 29, 2024EXPARTE APPEAL RECEIVED AT TTAB
Monday, July 29, 2024EX PARTE APPEAL-INSTITUTED
Monday, July 29, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, October 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 25, 2024EXPARTE APPEAL TERMINATED